2024-2025

Pharmaceutical Industry
Fellowship Program
2024-2025 FELLOWSHIP PROGRAM

Table of
Contents Steering Committee................................................................................................ 3
About Sanofi.............................................................................................................. 5
Sanofi at a Glance.................................................................................................... 6
Company History..................................................................................................... 7
Our People................................................................................................................. 8

1-Year Fellowship Global Medical Information.................................................................................... 10

2-Year Fellowships Clinical Science and Operations (CSO)............................................................... 11

Global Regulatory Affairs: Strategy..................................................................... 12
Patient Value and Strategy.................................................................................... 13
Public Affairs and Patient Advocacy.................................................................... 14
Regulatory Medical Writing................................................................................... 15
Strategic Marketing................................................................................................. 16
US Medical Affairs/Medical Strategy: Diabetes................................................ 17
US Medical Affairs: Transplant............................................................................... 18
US Trade/Market Access......................................................................................... 19

Not Recruiting Global Health Economics and Value Assessment (HEVA) and US Health
Economics and Outcomes Research (HEOR).................................................... 20
Global Regulatory Affairs: Advertising and Promotion................................... 21
Global Regulatory Affairs: Labeling..................................................................... 22
Global Regulatory Affairs: Regulatory Science
Partnership – Rutgers/Sanofi/FDA...................................................................... 23
Global Regulatory Affairs: Strategy and Advertising/Promotion................. 25
US Medical Affairs/Medical Strategy: Cardiovascular..................................... 26

Leadership Team...................................................................................................... 27
Fellowship Alumni..................................................................................................... 28
Rutgers Information and Application Process.................................................. 30

2
 2024-2025 FELLOWSHIP PROGRAM

Dear Candidates,
Thank you for your interest in our premier Pharmaceutical Industry Fellowship
Program with Sanofi and Rutgers University, Ernest Mario School of Pharmacy!

Our post-doctoral PharmD Fellowship offers opportunities across diverse

functional and therapeutic areas coupled with a seasoned Steering Committee and
dedicated Preceptors. We have seen the program grow to one of the largest and
most well-respected Fellowship programs in the industry with 22 Fellows at Sanofi,
part of the approximately 350 at Rutgers.

We are committed to our people, prioritizing inclusion while embracing diversity to

better meet the needs of our patients.

Over the last two decades, we have had the honor of hosting and mentoring
top talent and we look forward to growing the next generation of leaders in the
pharmaceutical industry. We are excited for you to consider our organization.

On behalf of the Sanofi Steering Committee, we wish you great success on your
career journey!

Best Regards,

Priti Lad, PharmD, Rutgers RPIF Stakeholder

Vince Cooper, PharmD, RPh Priti Lad, PharmD Juliette Muszka, PharmD, RPh Eric Racine, PharmD, MBA Joe Tuazon, PharmD, MSc
Sr. Director, Trade Accounts Therapeutic Area Head, Global Director, Health Value VP and Head, US Public Head, Global Medical
US Market Access - INPM Vaccines, Translation: Patient Informed Affairs and Patient Information Content &
Shared Services Global Regulatory Affairs Development & HVT Advocacy North America
Executive Sponsor Rutgers Stakeholder

3
2024-2025 FELLOWSHIP PROGRAM

Dear Candidates,
Thank you for considering the Pharmaceutical Industry Fellowship Program with Sanofi
and Rutgers University.

Our program is dedicated to developing top talent by providing PharmDs with a wealth
of valuable experiences to kickstart their careers in the pharmaceutical industry. We
offer an abundance of mentorship, leadership, and academic opportunities, as well as
an extensive network within Sanofi and other pharmaceutical companies nationwide.
We continue to uphold our goal to foster a diverse and inclusive program that provides
a robust foundation for our fellows to excel as the next generation of industry leaders.

As Co-Chief Fellows, we represent a strong cohort of 22 driven Sanofi fellows and

collaborate closely with our Fellowship Steering Committee and Executive Sponsors to
continuously optimize our program. We serve as a voice for the needs and interests of
our co-fellows to ensure they are seen and heard at Sanofi. Moreover, we are committed
to connecting our fellows with industry leaders across the organization and providing
unique growth drivers across different functional areas for fellows to explore the
breadth of opportunities at Sanofi. Above all, we are incredibly fortunate to have built
relationships with this remarkable class of co-fellows; relationships that will surely last
throughout our entire careers in the pharmaceutical industry.

We wish you the best of luck in the fellowship recruitment process and in your
flourishing career in the pharmaceutical industry.

Sincerely,
Lois Ko & Cole Mackey
Aman Kaur & Boseong Kang

Cole Mackey, PharmD, MBA Lois Ko, PharmD Aman Kaur, PharmD Boseong Kang, PharmD
US Trade/Market Access US Medical Affairs Global Regulatory US Medical Strategy:
Fellow 2022-2024 Fellow 2022-2024 Affairs Strategy Cardiovascular
Fellow 2023-2025 Fellow 2023-2025

4
2024-2025 FELLOWSHIP PROGRAM

About
To achieve these goals, we focus our
efforts on delivering our Play to Win
strategy, which is composed of four key
Sanofi priorities:

• We focus on growth, prioritizing our

portfolio to strengthen our company
profile
• We lead with innovation, bringing
transformative therapies to our patients
• We accelerate efficiency, taking
decisive actions to reinvest in our
pipeline
• We reinvent how we work, creating
an organizational culture that
empowers our people and promotes
accountability

We are committed to society, getting

medicines to the people who need
them most, taking better care of the
planet and reflecting the diversity of the
At Sanofi, we are a modern
communities we serve. Our Corporate
healthcare company bringing
Social Responsibility strategy focuses on
together dedicated, talented people
four building blocks aligned with our
and innovative science to transform
Play to Win core business strategy:
the practice of medicine. Today, we
are driven by a unifying purpose: • We commit to affordable access,
we chase the miracles of science ensuring global access and affordability
to improve people’s lives. We share to health, while helping healthcare
a common ambition: turning the systems to remain sustainable
impossible into the possible for
millions of people around the world. • We are at the cutting edge of Research
and Development for unmet needs,
Scientific discoveries do not happen helping people live fully
overnight or without hard work. It is • We care for the planet, minimizing the
our determination to find answers environmental impact of our business
for patients that motivates us as • We act in and beyond the workplace,
Sanofians to develop breakthrough giving all Sanofi colleagues the chance
medicines and vaccines, and to to become a leader of change, unlocking
transform medicine. the potential of our diverse teams

5
2024-2025 FELLOWSHIP PROGRAM

Sanofi
at a Glance
Sanofi is structured with four
global business units to support the
company’s Play to Win strategy:

General Medicines, Specialty Care,

Vaccines, and Consumer Healthcare

R&D Pipeline
As of April 2023, the R&D pipeline contained

Projects are in phase 3 or have been

78 Projects
24 submitted to regulatory authorities
for approval

Some of these are new molecular entities while others are existing products with
potential new indications or different formulations.

Industrial Network
We are committed to high standards of manufacturing
excellence, and our people produce healthcare solutions
to prevent and manage a broad spectrum of medical
conditions.

~ 34,000 67
people involved production sites

> 4.8
billion units of pharmaceuticals, consumer
healthcare and vaccines, including in-house
and outsourced production were sold in 2021

6
2024-2025 FELLOWSHIP PROGRAM

Company History
In the last half century, Sanofi has grown
into one of the world’s leading healthcare
companies – a culmination of a diverse group of
companies that share a rich history in healthcare
innovation dating back to the 19th century.

Today, our footprint extends to ~100 countries,

with ~100,000 employees perpetuating this
legacy and united under the common purpose
of chasing the miracles of science to improve
people’s lives.

• Our History •
BMP Sunstone, Medley, Merial,
Nepentes, Zentiva, Kendricks,
Oenobiol, Chattem, Acambis,
Symbion, Shantha Biotechnics, Genzyme
Fovea, Bipar Sciences, Targegen 2011
Genfar, Globalpharma, Bioverativ,
Kymab, Translate Bio Kiadis, Tidal,
Kadmon, Amunix
2008-2022

Sanofi-aventis
2004

Aventis Sanofi Pasteur Sanofi Synthélabo

1999 2004 1999

Marion Hoechst
Rorer Rhône-Poulenc Synthélabo Sanofi
1950 Marion Roussel
1910 1990 1970 1973
1997

Roussel Institut
Connaught Delagrange Delalande Sterling Chinoin Clin Midy
1911 Mérieux
1922 1931 1921 1901 19199 1971
1897

Wittman & Robert & Midy

Hoechst Dausse
Poulenc Carriere 1718
1863 1834
1860 1901

7
2024-2025 FELLOWSHIP PROGRAM

Our People
Our promise to our employees is
to pursue progress and discover
extraordinary together: better
science, better medications,
better outcomes. All that
progress needs people. People
from diverse backgrounds, in
various places around the world,
performing distinct roles all
united by one thing: a desire to
chase the miracles of science to
improve people’s lives.

Our employees are

people who: • Make miracles, taking Because when we bring the
• Explore more, sharing our thoughtful risks to find better best of our best selves every
purpose and our skills. solutions for the people we day, we can work miracles.
• Chase change and embrace serve. Diversity means taking
innovative ideas. competitive advantage of our
• Do right for our business, At Sanofi, our vision is to collective difference. Equity
patients, society and the reflect the diversity of our means fair treatment, access,
planet. We are committed to communities, unleash the full opportunity, and advancement
making the right decision and potential of our employees, for all. Inclusion means
taking action even when it is and transform healthcare to be ensuring that you belong, are
the harder thing to do. more inclusive and equitable. respected, and are valued.

Our DE&I Strategy is comprised of three pillars:

Reflect Unleash Transform

BUILDING CREATING AN ENGAGING

WORKFORCE INCLUSIVE WORKPLACE WITH OUR DIVERSE
DIVERSITY CULTURE COMMUNITIES
To leverage diverse perspectives To enable creativity and To positively impact the society
and be fully connected to our innovation through diversity, our in which we live and work,
patients’ and customers’ needs, we employees need to be able to we must be engaged with
must build leadership and teams bring their best selves to work and advocate for our diverse
that reflect the diversity of our so they can unleash their full communities.
communities. potential.

8
ognitions included: to creating a work environment that is
c Top 50 inclusive and empowers women across
Stephanie Veyrun-Manetti
General Manager Specialty Care
our organization to be successful and
oyers for Women
2024-2025 FELLOWSHIP PROGRAM
and Country Lead Canada represented in leadership roles.”
r Parity Certification in 2022 with
Organization
2022 DE&I Awards
Diversity,
abilityIN: Disability Equality Index (DEI)
man Rights Campaign (HRC)
ex (CEI)Equity, and
Inclusion
ramount Inclusion Index
s Top 100 Companies for the 12th Year
s Best Companies for Dads List for the
Our diversity, equity and
inclusion initiatives are the RATED

Best Companies for Multicultural

result of the dedication GOLD
ar of our employees and the
DIVERSITY,
EQUITY &
INCLUSION
2023
inclusive
’s Executive Women workplace they
List for the 5th Good Pharma

foster. Being recognized Scorecard

forRating)
g (Highest our efforts
in themeans we’re
Good Pharma
making a difference.
US Delivering Inclusive Studies Award

Sanofi Employee Resource Groups (ERGs) are key to our DE&I strategy as they tap into the
22
richness
Click hereof our diversity
to learn more aboutand offer employees a Click
US DE&I forum intowhich
here to exchange
learn more ideas,
about Corporate network,
Social and
Responsibility
gain exposure to different aspects of the organization. While company-supported and executive
sponsored, ERGs are managed by employees, enhancing career development and contributing
to their personal growth in the work environment. They are also a valuable asset for our company
to help deliver on business objectives. The strategy of all Sanofi ERGs is anchored in the 4Cs:
Community, Commerce, Culture & Careers. All employees are welcome in all ERGs – you do not
have to BE to belong.

Sanofi NA ERGs: Grass Root Engagement and the Voice of Employee Communities

Mosaic
Asian American
Black Employees
Disability Inclusion Multicultural-Canada Caregivers Developing Leaders & Pacific Islander
& their Allies
Employees & their Allies

Hispanic/Latino
Employees Impacted
Parents LGBTQ+ Veterans Women Employees & their
by Diabetes
Allies

North America
Indigenous
Awareness
With the focus on Four Cs: Careers, Culture, Commerce and
Community, the ERGs enable employees to connect around
a common experience or characteristic and are company
Every Generation Indigenous supported, executive sponsored and employee managed.
As of June 2023

9
RECRUITING ONE FELLOW

Global Medical
Information
Overview
The Global Medical Information department at Sanofi provides medical and drug information on Sanofi products
and therapeutic areas to healthcare professionals, consumers, and associates. Global Medical Information
Specialists offer expertise in specialty care, vaccines, general medicines, and consumer healthcare areas.

Goal
To provide the Fellow with the necessary tools to become a proficient, ethical, and confident
Global Medical Information Specialist.

Objectives
During this one-year Global Medical Information Fellowship, the Fellow will:
· Provide efficient and unbiased medical information on Sanofi products to healthcare
professionals, consumers, and employees
Andrew Gazo
· Develop strong literature searching and evaluation skills General Medicines
Content Head, Global
· Optimize written and verbal communication skills Medical Information
· Excel in teamwork and leadership skills
· Enhance professional growth in both the industry and academia

Sanofi Component
Author Scientific Response Letters. The Fellow creates and updates standard responses for
the Global Medical Information letter database in multiple therapeutic areas.
Respond to Medical Information Inquiries. The Fellow provides verbal and written responses
to drug and medical information requests in a timely fashion.
Sarah Soliman, PharmD
Literature Surveillance Using Internal and External Resources. The Fellow obtains and Content Manager, Global
maintains knowledge of current literature pertaining to products in his or her assigned Medical Information,
Vaccines
therapeutic areas by searching internal and external databases, including Medline and
Embase, while understanding their scope and focus.
Communication Skills. The Fellow enhances written and verbal communication skills through
interactions with healthcare providers, consumers, and internal stakeholders.
Teamwork/Leadership. The Fellow actively leads or contributes to projects within Global
Medical Information. The Fellow also serves as the student rotation coordinator for Doctor of
Pharmacy candidates.
Networking. The Fellow interacts with colleagues from other departments to learn about the
contribution of medical information to their daily activities. Sima Bhagat, PharmD
Global Medical Information
Research. The Fellow is expected to present a research poster at a prominent scientific Fellow 2023-2024
communications meeting to further the practice of Medical Information.
Additional Components. The Fellow enhances his/her medical information experience
through a rotation at a call-center (live, hybrid, TBD) covering multiple products and a
2-month external experience. The Fellow will also rotate within Global Medical Information to
gain experience across multiple therapeutic areas.

Ideal Candidate
· T he ideal candidate for this Fellowship would have a desire to gain experience in increasing
communication skills, evaluating literature, and applying clinical knowledge.
· Candidates with an interest in Medical Information, who demonstrate proactiveness and the ability to
work well on teams are encouraged to apply.

10
 RECRUITING ONE FELLOW

Clinical Science
and Operations
Overview
The Clinical Science and Operations (CSO) platform is responsible for the planning,
execution, and reporting of clinical trials at Sanofi. The cross-functional teams within CSO
are responsible for running trials to specific timelines, within budget, and to rigorous quality
standards. The 2-year CSO Fellowship is designed to provide the Fellow with multiple 3- to
6-month rotations during the first year before selecting their area of focus for the second
year. Preference for Therapeutic Area throughout the Fellowship will be highly considered. Monica Freese
Therapeutic Area Head,
Goal Rare Diseases and
Neurology
Provide the Fellow with insight into potential career paths in CSO while providing opportunity to Trial Operations
contribute to one or more clinical study teams.

Objectives
During the two-year program the Fellow will:
• Develop an understanding of how the various functions contribute to a clinical study team
• Develop working relationships with diverse internal and external stakeholders in a highly
matrixed organization
Divya Rana, PharmD
• Become familiar with clinical study documentation (e.g., protocol, investigator brochure,
Clinical Science
informed consent form, clinical study report); how they are designed, written, and distributed and Operations
during the course of a study Fellow 2022-2024
• Learn logistics of planning and conducting a clinical study including protocol development,
feasibility plan, recruitment plan, clinical data management, risk mitigation plan, study budget,
site/investigators selection, etc.
• Contribute to the data collection strategy and review patient profiles to learn and understand
the collection, review, and analysis of patient data
• Leverage various digital platforms to perform study feasibility and competitive intelligence
analysis taking into account the country, site, and patient perspective
• Contribute to special workstreams such as digital innovation to drive the implementation of Joseph Piotrowski, PharmD
digital tools across clinical studies and diversity and inclusion to increase patient diversity in Clinical Science
clinical studies and Operations
Fellow 2023-2025
• Build an extensive network internally with opportunities to meet and work with senior
managers, as well as opportunities to interact with research sites, vendors, and key opinion
leaders

Offered Rotations
• Trial Operations* • Data Management • Medical Advisor
• Early Development • Medical Writing • Clinical Supply
Operations • Clinical Study Unit • Diversity & Inclusion Prakrithi Ramesh, PharmD
• Early Development • Feasibility (Site Selection) Clinical Science
Oncology Operations** and Operations
Fellow 2023-2025
* Requirement ** Duration: Six months

Ideal Candidate
The ideal candidate for Clinical Science and Operations should have:
• Leadership and independent thinking skills to optimize efficiency and execute tasks
• Effective written and verbal communication skills to facilitate cross-functional teamwork
• Flexibility to adapt to changes in a dynamic working environment

11
RECRUITING ONE FELLOW

Global Regulatory Affairs

Strategy
Overview
The Global Regulatory Affairs (GRA) team at Sanofi works to provide regulatory
expertise using innovative and prompt guidance for product development and life cycle
Priti Lad, PharmD
management of marketed products. Therapeutic Area Head,
INPM Vaccines,
Goal Global Regulatory Affairs

This Fellowship is focused on providing the fellow with the necessary skills and tools to become
a knowledgeable, confident, and strategic regulatory affairs professional. The Fellow will gain
hands-on experience across a variety of areas within the GRA department, developing a well-
rounded understanding of the regulatory functions and drug development process from early
stage to post-marketing.

Objectives
During this two-year GRA Fellowship, the Fellow will:
Yenny Ramos, MS MV
• Develop regulatory strategic skills while contributing to global pre- and post-approval Director, Global Regulatory
planning and submissions potentially including briefing documents, Health Authority Lead INPM Vaccines
interactions, IND/CTA submissions, BLA/NDA/MAA applications
• Lead team meetings, develop regulatory strategy, and contribute to and lead Health
Authority submissions with increasing responsibility throughout the Fellowship program
• Partner with contributing functions within Sanofi to deliver products for diseases globally
• Experience various facets of GRA to better understand the roles of regulatory professionals
• Engage with global colleagues and learn country/region-specific regulatory processes
• Develop skills such as strategic and analytical thinking, effective communication, business
acumen and partnering/collaboration Amanda Meisel, PharmD
Senior Manager, US Lead,
Sanofi Component Regulatory Affairs

Become an integrated part of the GRA team through involvement in cross-functional projects
with global colleagues. The Fellow will gain experience in areas of GRA such as:
· Global Regulatory Product Strategy
· Advertising and Promotion
· Global Labeling
· Regulatory CMC & Devices
· Regulatory Digital/Innovation
Aman Kaur, PharmD, MS
· Regulatory Science and Policy
Global Regulatory
· Others Affairs Strategy
Fellow 2023-2025

Ideal Candidate
The ideal candidate for this fellowship has the desire to learn the skills needed for developing regulatory
strategy for products in both the pre-approval and post-approval setting. Candidates must also be
motivated to collaborate with multidisciplinary teams to meet business objectives. Candidate should be
open to learning and interpreting regulations and developing an effective and strategic plan. Candidates
with a passion for science, independent work ethic, interest in working collaboratively, solutions-oriented
mindset, and strong time management skills are encouraged to apply.

12
RECRUITING ONE FELLOW

Patient Value
and Strategy
Overview Paul Cox, PhD
The biopharmaceutical industry provides innovative solutions to meet the evolving Global Director, Health Value
demands of health authorities while garnering patient, provider, pharmacist, policymaker, Translation, Patient Informed
Development & Health Value
and payer (5P) insights. Our Sanofi Global Patient Informed Development and Health Translation
Value Translation (PID&HVT) team is committed to driving patient-centered drug
development to improve health outcomes.

Goal
This two-year program offers the tools for the Fellow to develop their core competencies
and succeed as an industry professional who can confidently formulate patient stakeholder
value.
Patricia Roselle
Objectives Head, Patient Stakeholder
Engagement, Patient Informed
· Optimize the value of R&D assets across the specialty care portfolio Development & Health Value
Translation
· Define evidence-based value propositions that address unmet needs of the 5P’s
· Support and expand digital strategies to capture patient perspectives
· Prepare and participate in advisory panels
· Research policy requirements for patient informed development trends
· Develop the ability to think strategically and collaborate within a global matrix team

Sanofi Component
Beth Brooks, MPH
Integration. The Fellow will work with members of numerous departments including Head, Patient Insight &
Global Research & Development, Medical, Public Affairs and Patient Advocacy, Regulatory Behavioral Science, Patient
Affairs, Health Economics & Value Access, Real-World Evidence, New Product Planning, Informed Development & Health
Competitive Intelligence, Market Research and Commercial Strategy cultivating professional Value Translation
relationships.
Knowledge. The Fellow will develop presentations across multiple therapeutic areas and
learn the essential elements of a disease value assessment with a deep understanding of
patient care.
Communication. The Fellow will participate in team meetings and webinars where they will
employ industry nomenclature and improve both written and verbal communication skills.
Networking. The Fellow will network with Sanofi professionals across the organization as Tola Akinnuoye,
well as the extensive Fellowship community. PharmD, MPHc
Patient Informed
Development & Health
Value Translation
Fellow 2022-2024

Ideal Candidate
Innovative self-starter with a growth mindset who has a:
· Strong background in clinical pharmacy and PATIENT CARE Reyna Jash, PharmD, MBA
Patient Informed
· Desire to excel in patient-centric PRODUCT DEVELOPMENT Development & Health
Value Translation
Fellow 2023-2025

13
RECRUITING ONE FELLOW

US Public Affairs &

Patient Advocacy
Overview
The US Public Affairs and Patient Advocacy (US PA&PA) team partners with US patient advocacy groups
and professional societies to champion issues critical to patients. Coordinating the company’s approach
with external advocates requires active engagement and extensive collaboration with various internal,
cross-functional teams across all parts of the company.
As an active member of the healthcare ecosystem, Sanofi is dedicated to the needs of patients and finding
collaborative solutions. Our goal is to be a partner who listens, acts, and leads to improve patient health,
accelerate medical innovation, and facilitate access to medicines and vaccines. US PA&PA bridges the
insights, knowledge, and resources of both the external advocacy community and within Sanofi to support
advocacy initiatives that matter most to patients.

Goal
To provide the US Public Affairs and Patient Advocacy Fellow with necessary hands-on
experience, knowledge, and skills to make a positive impact on patient health outcomes.

Objectives
During this two-year program, the Fellow will:
Eric Racine, PharmD, MBA
· Build and maintain external advocacy relationships by liaising with US patient groups, medical Vice President, US Public
and professional societies, health foundations, and other stakeholders in the advocacy Affairs and Patient
Advocacy
community to inform internal decision-making and patient-centric initiatives
· Enhance their understanding of the US healthcare system through leadership on cross-
functional projects that aim to develop timely, evidence-based, patient-centric solutions
· Develop and enhance critical skills while working with colleagues across Corporate Affairs,
R&D, Medical, and Commercial teams to manage partnerships and projects in a global,
diversified healthcare solutions company
· Strategically network and build meaningful relationships with internal leadership and external
advocacy leaders across the healthcare ecosystem
Bernadette Wang, PharmD
Head, US Public Affairs and
Sanofi Component Patient Advocacy,
Neurology
The Fellow’s core experience will be within the Sanofi General Medicines therapeutic areas
(Transplant, Type 1 Diabetes, and Cardiometabolic). There will be additional opportunities to
gain experience within the Specialty Care (Rare Blood Disorders, Rare Diseases, Immunology,
Neurology, and Oncology) and Vaccines therapeutic areas, if desired.
Outside of their experiences in US PA&PA, the Fellow may also have rotational or project
experience(s) in other areas of the company to further enhance their professional development,
including Global Public Affairs & Patient Advocacy, Reimbursement & Public Policy, Science
Policy, Federal and State Government Relations, Communications and Corporate Social
Madison Blagrove, PharmD
Responsibility, and Market Access. US Public Affairs & Patient
Advocacy, General
Medicines
Fellow 2022-2024

Ideal Candidate
The ideal candidate for the Public Affairs and Patient Advocacy Fellowship would have a desire to learn
and understand the US healthcare landscape via internal and external collaboration with key leaders.
Candidates with a passion for patient advocacy, robust interpersonal communication skills, interest in
working cross-functionally, and ability to think strategically are encouraged to apply.

14
RECRUITING ONE FELLOW

Regulatory
Medical Writing
Overview
Research, development, and approval of new drugs and drug delivery systems are essential for providing
better treatment options to patients. Approval of these new drugs and devices requires rigorous testing,
collection and analysis of data, and unbiased reporting of the efficacy and safety of the findings. The Clinical
Documentation Department is responsible for translating clinical components into documentation that ensures
timely delivery of unbiased clinical results to health authorities worldwide for marketing approval and life cycle
maintenance.

Goal
To provide the Fellow with exposure, training, and experiences for a broad set of skills and
documents required for the development, registration, and maintenance of drug products in
accordance with local and global Health Authority requirements.

Objectives
During this two-year program, the Fellow will:
Life Cycle of Drug Development. Understand processes involved in progression from study
Madhavi Gidh-Jain, PhD
concept to completed clinical study report and from product development plan to marketed Sr. Director, Medical Writing
product.
Clinical Documentation Expertise. Develop essential knowledge of the different skill
requirements and dependencies of each field of expertise within Clinical Documentation:
Medical Writing, Trial Transparency, Quality Control, Electronic Document Management, and
Resourcing.
Critical Evaluation of Clinical Data. Expand scientific and medical knowledge of products in
various therapeutic areas and enhance skills to critically evaluate, interpret, synthesize, and
present an unbiased interpretation of results for various audiences through close collaboration
with multiple departments across the organization.
Understanding of Health Authority Regulations. Develop a working knowledge and core Nancy Nguyen, PharmD
Regulatory Medical Writing
understanding of the different regulatory requirements across regions based on projects Fellow 2022-2024
assigned. Make hands-on contributions to the strategy, writing, and management of clinical
documents in support of clinical trial teams, submission activities, and the life-cycle of a product.

Sanofi Component
Knowledge. With a concentration in Medical Writing, the Fellow will gain experience writing a variety of clinical and
regulatory documents such as New Drug Applications, Common Technical Documents, Investigational New Drug
Applications, Clinical Study Reports, and Investigator Brochures.
Ethics. The Fellow will understand issues around compliance, confidentiality, transparency, and professional ethics
that govern the activities of Clinical Documentation.
Leadership/Teamwork. The Fellow will Develop international work experience both within the department and
as a member of global cross-functional clinical project teams including Biostatistics & Programming, Clinical Trial
Operations and Data Management, Pharmacovigilance, Regulatory, Pharmacokinetics, Clinical and Exploratory
Pharmacology, and Evidence-Based Medicine, among others.

Ideal Candidate
The ideal candidate should have:
· Effective communication skills to facilitate cross-functional teamwork across various departments
· An interest in clinical documentation and the desire to learn the different components that go into
submissions
· Strong independent work ethic and time management skills
15
RECRUITING TWO FELLOWS

Strategic
Marketing
Overview
At Sanofi, Marketing serves a central role in understanding customer needs and creating
valued brands. The Fellows within these roles will be provided with marketing excellence
training in one of the following therapeutic areas, based on personal interest and experience:
Solid Organ Transplant or Cardiovascular/Diabetes. Each Fellow will develop key competencies
of a successful product manager within their field according to the marketing model.

Goal
Solid Organ Transplant Marketing Rasha Masoud, PharmD
The primary focus of this fellowship is building a marketing skillset that supports the growth of Head, Cardiometabolic
Sanofi Transplant brands at various stages of life cycle management. The Marketing Fellow will Marketing
assist in the development and implementation of campaigns to enhance availability and equity
in living donor kidney transplantations. Additionally, the Fellow will utilize analysis of public
policy to assist in promoting the value of, and increasing access to, transplantation among
payers and patients, respectively. Candidates applying to this position are preferred to have
high level interest and experience in solid organ transplant.

Cardiovascular/Diabetes Marketing
The primary focus of this fellowship is market development and commercialization of Sanofi
cardiovascular and diabetes brands, including a first-in-class preventative therapy for Type 1 Veronica Martinez
US Brand Lead,
Diabetes. The Marketing Fellow will have the opportunity to increase brand presence through Thymoglobulin/Solid Organ
the execution of cross-functional strategies in advertising and promotion, patient and provider Transplantation
education, and patient advocacy. The Fellow will gain unique exposure to both mature and
first-in-class brands, deepening their depth of marketing skills and experience.

Objectives
During the two-year program, the Strategic Marketing Fellows will:
• Assist in the development of strategic and tactical plans
• Gain experience in execution of marketing strategics, programs, and tactics to attain
strategic objectives
Morgan Weber, PharmD
• Contribute to brand success by working effectively with multiple agency partners, vendors, Strategic Marketing
and cross-functional colleagues Fellow 2022-2024
• Oversee initiatives driving product awareness at major national medical congresses and
symposia

Sanofi Component
Strategic Planning. Exhibits strong strategic thinking and an ability to apply core marketing,
financial, and business skills when solving problems and making decisions. Demonstrates an
aptitude for translating strategic goals into clear action plans and tactical implementation.
Analytical Thinking. Identifies, gathers, and rigorously analyzes relevant information as a Jessica Blaze, PharmD, MBA
framework for identifying trends and opportunities to transform and adapt brand strategies. Strategic Marketing
Creativity & Innovation. Displays creativity in both thought process and solution design, while Fellow 2023-2025
demonstrating the ability to develop and champion new ideas within the organization.

Ideal Candidate
The ideal candidate for the Strategic Marketing fellowship has strong written and verbal communication
skills, works collaboratively within a team, is comfortable executing tasks with minimal oversight, and
portrays exemplary leadership skills.

16
RECRUITING ONE FELLOW

US Medical Affairs
Medical Strategy: Diabetes
Overview
· The fellow will serve as a core member of the home office Medical Team, working
directly with Medical leadership to contribute to the development of Medical
Strategy and its application to US and Global markets
· The fellow will work to align the Medical Strategy tactical plan across matrix teams
(Marketing, Medical Information, Patient Advocacy, Legal, and Regulatory)
· The fellow’s primary responsibility is to support the needs of the Medical Team,
while being offered the unique opportunity to expand experience with projects in
additional areas of interest

Goal
To become an effective member of a cross-functional Medical Affairs Team by developing the Jasvinder Gill, PhD
transferrable skillset for future career success across various therapeutic areas. Sr. Medical Director,
US Diabetes
Medical Affairs
Objectives
During this two-year US Medical Affairs Fellowship, the fellow will:
· Gain a thorough understanding of Medical Affairs while collaborating cross-functionally
(e.g., Commercial, Regulatory, etc.) to apply learnings to US and Global perspectives
· As a core team member, contribute to both US and Global projects that directly impact
brand development and life cycle management
· Execute the development and planning of National and International Congresses and
Advisory Board meetings with top-tier Key Opinion Leaders (KOLs)
Lois Ko, PharmD
· Assist in the development of Strategic and Tactical Plans US Medical Affairs
· Engage digital opinion leaders (DOLs) in scientific discussion and tactical plans to target Fellow 2022-2024
the individual needs of HCPs and patients in the diabetes space
· Work with Scientific Communications groups to support Sanofi Diabetes products
· Work in collaboration with the Omnichannel Lead to deliver a best-in-class customer
experience through all medical channels that will drive medical strategy
· Opportunity to expand experiences to other business units of General Medicines

Mariam Hanna, PharmD

US Medical Affairs
Fellow 2023-2025

Ideal Candidate
The ideal candidate for the Medical Affairs Fellowship would have a desire to learn medical strategy,
tactics, and scientific communication, as well as to participate in digital innovation and Omnichannel-
related activities that a medical affairs professional completes in a global pharmaceutical organization.
Candidates with a passion for science, strong independent work ethic, interest in working collaboratively,
ability to communicate scientific information, and skilled in time management are encouraged to apply.

17
RECRUITING ONE FELLOW

US Medical Affairs:
Transplant
Overview
· The Fellow will serve as a Core Member of the Medical Team, working directly with Medical
Leadership to contribute to the development of US Medical Strategy
· The Fellow will work to align the Medical Strategy tactical plan across matrix teams (Global
Medical, Marketing, Field Medical, Medical Information, Advocacy, Clinical Development,
Legal and Regulatory)
· The Fellow’s primary responsibility is to support the needs of the Medical Team, while
being offered the unique opportunity to expand experience with projects in additional
areas of interest
Goal
To become an effective member of a cross-functional Medical Affairs Team by developing the
transferrable skillset for future career success across various therapeutic areas.
Kenneth ‘Troy’
Objectives Somerville, PharmD
Head, US Medical
During this two-year US Medical Affairs Fellowship, the Fellow will: Transplantation
· Gain a thorough understanding of Medical Affairs while collaborating cross-functionally
(e.g., Global, Commercial, Field Medical, Regulatory, etc.) to apply learnings to US and
Global perspectives
· As a core team member, contribute to both US and Global projects that directly impact
brand development and life cycle management
· Execute the development and planning of National and International Congresses and
Advisory Board meetings with top-tier Key Opinion Leaders (KOLs), in addition to
field-related initiatives Sara Hammad, PharmD
· Facilitate discussion and identification of insights from the field and various matrix teams Associate Director, US
Medical Transplantation
to determine unmet medical needs and competitive intelligence insights to inform medical
strategy
· Lead projects that positively impact new business opportunities and contribute to
team success
· Participate in potential clinical development opportunities within the transplant
therapeutic areas
· Opportunity to engage thought leaders in scientific discussion during field-based
activities with Medical Science Liaisons (MSLs) and gain MSL certification
· Ability to work with the Publications and Scientific Communications groups to support Eugina Chiang, PharmD
Sanofi Transplant products and opportunity US Medical Affairs/Medical
Strategy: Transplant
· Work in collaboration with Health Economics Outcomes and Real World Evidence Groups Fellow 2022-2024
to generate impactful data aimed to improve the utilization of our therapies

Ideal Candidate
The ideal candidate for the Transplant Medical Affairs Fellowships would have a desire to learn medical
strategy, tactics, and scientific communication, as well as to participate in data generation and publication
related activities that serve as the foundation of a medical affairs role within a global pharmaceutical
organization. Candidates with a passion for science, interest in solid organ transplant and/or bone marrow
transplant, strong independent work ethic, ability to work collaboratively, and skills in time management
are encouraged to apply.

18
RECRUITING ONE FELLOW

US Trade/
Market Access
Overview
The US Market Access Shared Services team plays an integral part in supporting the Market
Access organization (e.g., Payer and Value & Access teams) across the Specialty Care and
General Medicines portfolio at Sanofi. The Shared Services functions (US Wholesale Trade &
Channel Management, Horizon Scanning, Contract Development and Pricing) ensure Sanofi
has an organized approach to its customers (payers, distribution partners, and other channel Vince Cooper, PharmD, RPh
vendors) while aligning with commercial brand team objectives to improve patient access to Sr. Director, Trade Accounts
life-saving medicines. US Market Access -
Shared Services

Goal
The Fellow will gain experience in market access and channel management across the following
business units: General Medicines (Transplant, Type 1 Diabetes, Cardiometabolic) and Specialty
Care (Immunology, MS, Oncology, Rare Diseases and Rare Blood Disorders). The Fellow will
complete Core and Elective rotations in the following areas: US Trade, US Value & Access, Patient
Support Services, Pricing & Contracting, Specialty Channel Management, and Horizon Scanning
& Payer Innovation.
Keith McGee, PharmD, RPh
Objectives Sr. Director,
Channel Management
· Understand the evolving US drug reimbursement landscape and development of payer
strategy for products in various therapeutic areas
· Acquire an in-depth understanding of the overall pharmacy channel during product launch
and support throughout its lifecycle
· Learn and interact with a broad range of activities and teams including: Sales, Marketing,
Commercial Excellence, Medical, Regulatory, Legal, and Public Affairs
· Gain experience in project management and vendor management by managing and leading
multiple projects and cross-functional workstreams
Cole Mackey, PharmD, MBA
· Gain significant exposure to Trade customers and commensurate Professional Conference US Trade/Market Access
Engagement Fellow 2022-2024

Sanofi Component
Knowledge. The Fellow will develop an extensive knowledge and fluency across multiple
therapeutic areas. Specialized training opportunities are available, such as attendance at
professional meetings, key thought leader lectures, and internal sessions.
Leadership/Communication. The Fellow will develop leadership and communication skills, while
working in collaboration with internal and external customers.
Emily Wong, PharmD, MBA
US Trade/Market Access
Fellow 2023-2025

Ideal Candidate
· O utstanding business acumen; understands the healthcare industry and other marketplace
factors/dynamics
· Ability to work with highly integrated accounts in payer, wholesale, retail and specialty pharmacy space;
looking to develop business capabilities and innovative solutions that benefit patients across the
Sanofi portfolio
· Self-starter, learning attitude, open to become an expert across customer types and multiple
therapeutic areas

19
 NOT RECRUITING

Global Health Economics

and Value Assessment (HEVA)/
US Health Economics and
Outcomes Research (HEOR)
Overview
This two-year Fellowship places the Fellow in Sanofi’s Global Health Economics and Value Assessment (HEVA)
and US Health Economics and Outcomes Research (HEOR) organizations. HEVA/HEOR have the mission of
developing, translating, and communicating scientific evidence for use by health care providers, payers,
and other customers to facilitate access and use of the best treatments for patients. A principal objective of
HEVA/HEOR is to demonstrate the value that Sanofi products bring to payers and other healthcare providers.
HEVA/HEOR accomplishes this goal by generating and publishing research studies, conducting collaborative
projects with various stakeholders, and partnering with other functions of the broader Sanofi organization to
develop solutions that address unmet medical needs and product value propositions.

Fellowship Description
The HEVA/HEOR Fellow will rotate through various US HEOR and Global HEVA functions, learning
core skills related to conducting prospective and retrospective research studies, publishing
data in scientific journals, developing customer support tools, and interacting with payers and
stakeholders. This Fellowship will provide a balanced exposure to best practices related to
developing and communicating evidence, as well as a solid working knowledge of regulatory and
legal guidelines inherent to these capabilities. The Fellow can take advantage of the opportunity, Ron Preblick, PharmD, MPH
to take Rutgers coursework in the areas of Health Outcomes, Policy, and Economics. The Fellow Head, US General Medicines
is expected to grow professionally throughout their experience, engaging in projects of varying HEOR
complexity and ultimately managing selected responsibilities with greater levels of independence.

Objectives
Upon completion of the experience, the HEVA/HEOR Fellow will be prepared to contribute within
pharmaceutical organizations in numerous ways by drawing upon the following sample of skills
developed:
• Design of outcomes research studies; use of descriptive and inferential statistics
• Publication within scientific/medical journals
• Resource development for use in patient treatment decisions Marvin Nguyen, PharmD
Global HEVA/US HEOR
• Identification of unmet medical needs to drive research and communication planning Fellow 2022-2024
• Project management, including vendor supervision and common metrics reporting
• Working knowledge of relevant regulatory and compliance requirements
• In-depth understanding of the US and Global healthcare environment, and the influence of
payers on patient access to medicines

Ideal Candidate
The ideal candidate for the Fellowship would like to learn a wide variety of skills as part of a challenging
group within a global pharmaceutical organization. Candidates with interest in health economics,
outcomes research, communication/publications, healthcare reform, and collaboration with various
healthcare stakeholders in the development of products, solutions, and technologies for optimal patient
care are particularly encouraged to apply.

20
NOT RECRUITING

Global Regulatory Affairs

Advertising and Promotion
Overview
As part of Sanofi’s Global Regulatory Affairs group, the Advertising and Promotion team strives to provide
innovative, detailed, and effective regulatory expertise and strategic guidance. These actions ensure
optimal management of marketed and development products, in addition to effective and compliant
advertisement and promotion of marketed products.

Goal
The focus of this Fellowship is to provide the Fellow with the necessary skills and tools to
become a knowledgeable and confident Regulatory Affairs professional with the experiences
and opportunities to interact with multidisciplinary teams. The Fellow will fulfill the responsibility
of ensuring advertisement and promotion materials are compliant with FDA regulations and
corporate policies and accurately reflect the unique characteristics of our products and
company.
Jesal Patel, PharmD
Objectives Associate Director, Global
During this two-year GRA Advertising and Promotion Fellowship, the Fellow will, among other Regulatory Affairs
things:
· Become knowledgeable of current FDA regulations, guidances, enforcement actions and
trends related to the promotion of prescription drugs and biologics
· Become knowledgeable in Sanofi’s Review Committee (RC) processes and develop
necessary skills for reviewing commercial materials intended for external and internal
audiences, in accordance with federal regulations and Sanofi policies
· Develop the skills necessary to prepare required FDA reports and other submissions
· Analyze the impact of FDA Office of Prescription Drug Promotion (OPDP) enforcement
Jonathan Resch, PharmD, MBA
actions and assess the regulatory implications Global Regulatory Affairs
· Collaborate with multidisciplinary teams on the development of marketing campaigns to Advertising and Promotion
ensure we meet regulatory requirements and commercial objectives Fellow 2022-2024

During the second year, upon discussion with the preceptor, the Fellow can choose to explore
other areas of GRA. This includes but is not limited to; Strategy, Labeling, Science & Policy, or
continue in Advertising and Promotion.

Sanofi Component
· Understand and become a subject matter expert of current FDA regulations and guidances
· Assist in preparing FDA correspondences, documents, and submission packages
· Become an integrated part of relevant Sanofi RCs
· Involvement in cross-functional projects with global colleagues
· Teamwork/leadership
· Networking

Ideal Candidate
The ideal candidate for the Fellowship has the desire to learn the skills needed in the Regulatory review
of commercial materials. The ultimate goal for the Fellow is to become a knowledgeable and confident
Regulatory Affairs professional. Candidates with a passion for science, independent work ethic, interest in
working collaboratively, solutions-oriented mindset, and strong time management skills are encouraged to
apply.

21
 NOT RECRUITING

Global Regulatory Affairs

Labeling
Overview
At Sanofi, Global Regulatory Affairs (GRA) Labeling strives to enable healthcare providers, caregivers,
and patients to make the best-informed decisions for patients and themselves by delivering the most
relevant, useful, scientifically accurate, and current information about Sanofi products’ benefits and
risks. GRA Labeling develops global labeling strategy and incorporates the operating principle of
“Label as Driver” into the project team’s way of working and decision making.

Goal
To provide the Fellow with the necessary tools to become a knowledgeable and confident
Regulatory Labeling professional. The Fellow will be provided with the opportunity to fulfill
broad regulatory labeling responsibilities for marketed products and investigational compounds
in development, in accordance with applicable laws, global health authority regulations, and
company policies.

Objectives Paragi Patel, PharmD

Associate Director, Global
During this two-year GRA Labeling Fellowship, the Fellow will, among other things: Regulatory Affairs Labeling
• Develop necessary skills for authoring and facilitating development of corporate, US, and EU
labeling for products in development and marketed products in Sanofi’s portfolio
• Gain knowledge and understanding of the drug development process and the role of labeling
in the lifecycle of a product
• Become knowledgeable of current FDA, EMA, and other health authority regulations,
guidances, and current industry standards impacting product labeling and beyond
• Develop the skills necessary to lead cross-functional matrix teams to deliver optimal label
content (Labeling Working Group) and gain approval through governance processes
Zachary Becouvarakis,
• Understand the importance of labeling strategy related to the development and negotiation PharmD
of labeling for investigational compounds and marketed products with health authorities Global Regulatory
Affairs Labeling
• Support local affiliates with implementation of core labeling information into local labels Fellow 2023-2025
• Develop submission-ready labeling documents which are in line with applicable laws,
regulations, and guidances
• Gain experience and understanding through a 3-6 month rotation in another area in GRA

Sanofi Component
• Awareness and understanding of current FDA Regulations and Guidances
• Become an integrated part of relevant Sanofi Development Team
• Communication
• Teamwork/leadership
• Networking

Ideal Candidate
The ideal candidate for this Fellowship would have a desire to learn regulatory labeling strategy, to
become knowledgeable in global labeling regulations and guidances, as well as to develop the skill of
thinking globally while working in a culturally diverse environment. Candidates with a passion for science,
strong independent work ethic, strong verbal and written communication skills, interest in working
collaboratively, and time management skills are encouraged to apply.

22
NOT RECRUITING

Global Regulatory Affairs

Regulatory Science Partnership
Rutgers/Sanofi/FDA
Overview
This unique experience is a formed partnership between Rutgers University Ernest Mario School of
Pharmacy (EMSOP), Sanofi Regulatory Affairs, and the FDA Office of New Drugs. The fellowship is
structured in three consecutive 8-month rotations aimed at providing an understanding of:
• The provision of competent, compassionate, evidence-based, and patient-centered pharmaceutical care
that improves medication safety and prevents medication misadventures. This clinical practice foundation
will occur through Rutgers EMSOP, providing a foundation applicable to various professional settings
moving forward.
• The processes within Sanofi to develop innovative, effective, and rigorous regulatory strategies that ensure
optimal management of novel development products and/or effective life cycle management of marketed
products to benefit patients.
• The basics of the drug approval process and the regulatory framework to obtain data in pregnant and
lactating women and children. The participant will have the opportunity for scientific exchange with
reviewers across multidisciplinary teams in the Office of New Drugs and the Office of Surveillance and
Epidemiology.

Goal
To provide the fellow with the experiences and opportunities to interact with a variety of
multidisciplinary teams to fulfill broad regulatory responsibilities for marketed products and
investigational compounds in development. The program provides participants with the unique
opportunity to learn from mentors across three diverse settings in academia, industry, and
government.

Objectives
Priti Lad, PharmD
During this two-year Regulatory Science Fellowship, the fellow is expected to dedicate: Therapeutic Area Head,
• Approximately eight months of a clinical rotation experience, provided by Rutgers University INPM Vaccines, Global
Regulatory Affairs
EMSOP in Piscataway, NJ at associated clinical practice site(s)
• Approximately eight months of regulatory strategy exposure at Sanofi in the Global
Regulatory Affairs organization in Bridgewater, NJ with travel expected as needed to the site
• Approximately eight months at FDA, Division of Pediatrics and Maternal Health (DPMH) in the
Office of New Drugs, Center for Drug Evaluation and Research in Silver Spring, MD (currently
a remote work environment)

Rutgers Rotation
While completing the Rutgers rotation, the Fellow will have the opportunity to strengthen
clinical practice skills and deepen understanding of interprofessional delivery of health care. Tiffany Lin, PharmD
Learning opportunities may include effectively managing practice-based projects and overall Global Regulatory
medication-use process, participating in protocol development and/or implementation, Affairs Partnered
providing drug information, precepting students, and educating/training patients, healthcare Fellow 2023-2025
professionals, and the community. The Fellow will develop clinical, communication, and
leadership skills necessary to provide high quality care and optimal patient outcomes and be
able to leverage those skills and knowledge gained in both the Sanofi and FDA segments of this
two-year Regulatory Science Fellowship.

(continued)
23
Sanofi Rotation
While completing the Sanofi Regulatory Affairs rotation, the Fellow will achieve fundamental understanding of
decision points and criteria, how scientific issues and stakeholder needs affect product development strategy
(including patient and payer perspectives), and the process of bringing needed products to patients. Experiences
may include:
• Gain insight into developing regulatory strategy for pipeline and/or marketed programs
• Develop proficient communication skills when interacting with internal and external stakeholders
• Become knowledgeable of current ICH and US regulations, FDA guidance documents, and applicable policies
and participate in the analysis of current and planned legislation, regulations, policies and/or guidances,
targeting information from multiple sources
• Exposure to cloud and other new technologies and potential for new opportunities with Sanofi and the industry
• Participation in inter company and intracompany initiatives in the Regulatory Affairs area, including
collaboration with deeply experienced thought leaders in the regulation discipline
• Develop the skills necessary to prepare various regulatory submissions

FDA Rotation
While completing the FDA rotation, the Fellow will gain short-term immersion experience in a structured program
led by regulatory experts and focused on the regulatory evaluation of drug and biologic products in pregnant and
lactating women, and children. Learning experiences could include elements of clinical trial design, biostatistics,
pharmacology, toxicology, risk management, pharmacovigilance, epidemiology, and the ethical and legal
framework of regulation. This framework will provide exposure to important aspects of drug development through
the review of pregnancy, lactation, and pediatric issues within the drug development lifecycle. To increase the
practical application of knowledge gained during the rotation, participation in a regulatory science project is
expected. Experience with data analysis is preferred.

24
NOT RECRUITING

Global Regulatory Affairs

Strategy/Advertising and Promotion
Overview
The Global Regulatory Affairs Strategy (GRA) team at Sanofi works to provide regulatory expertise using
innovative and prompt guidance for product development and life cycle management of marketed
products. The Advertising and Promotion team ensures effective and compliant promotion of marketed
and development products.

Goal
This Fellowship is focused on providing the fellow with the necessary skills and tools to become
a knowledgeable and confident Regulatory Affairs professional. During the first year in Strategy,
the Fellow will work in accordance with applicable laws, FDA regulations, and company policies
for marketed products and investigational compounds in development. The next year in
Advertising and Promotion, the Fellow will ensure promotional materials are compliant with
FDA regulations and corporate policies to accurately reflect the unique characteristics of our
products and company. Patricia Johnson
Head, US Regulatory
Expert
Objectives
The first year of this Fellowship will focus on GRA Strategy and the second year will focus on GRA
Advertising and Promotion:
· Obtain experience in preparing for and attending FDA meetings and rehearsals, along with
insight on developing US regulatory strategy for pipeline and marketed programs
· Become knowledgeable of current ICH and US regulations, FDA guidance documents, and
applicable policies to prepare for various FDA submissions
· Become knowledgeable of current FDA regulations, guidances, enforcement actions and
trends related to the promotion of prescription drugs and biologics Jesal Patel, PharmD
Associate Director,
· Become knowledgeable in Sanofi’s Review Committee (RC) processes and develop necessary Global Regulatory Affairs
skills for reviewing commercial materials intended for external and internal audiences, in
accordance with federal regulations and Sanofi policies
· Collaborate with multidisciplinary teams on the development of marketing campaigns to
ensure we meet regulatory requirements and commercial objectives

Sanofi Component
· Understand and become a subject matter expert of current FDA regulations and guidances
· Support in the execution of FDA Meetings
Matthew Grubic, PharmD
· Assist in preparing FDA correspondences, documents, and submission packages
Global Regulatory Affairs
· Become an integrated part of relevant Sanofi Development Teams (GRA Strategy) and Sanofi Strategy/Advertising
RCs (GRA Ad/Promo) and Promotion
Fellow 2023-2025
· Involvement in cross-functional projects with global colleagues
· Teamwork/leadership/networking

Ideal Candidate
The ideal candidate for this Fellowship has the desire to learn the skills needed for developing regulatory
strategy for products in development and preparing for FDA meetings and rehearsals. Candidates
must also be motivated to foster the skills needed for regulatory review of commercial materials and
collaboration with multidisciplinary teams to meet commercial objectives. Candidate should be open to
learning and interpreting regulations and developing an effective and strategic plan. Candidates with
a passion for science, independent work ethic, interest in working collaboratively, solutions-oriented
mindset, and strong time management skills are encouraged to apply.

25
NOT RECRUITING

US Medical Affairs
Medical Strategy: Cardiovascular
Overview
· The Fellow will serve as a Core Member of the Home Office Medical Team, working directly with Medical
Leadership to contribute to the development of Medical Strategy, co-leading key Medical projects, and its
application to US and Global markets
· The Fellow will work to align the Medical Strategy tactical plan across matrix teams (Marketing, Field
Medical, Medical Information, Advocacy, HEVA, HEOR, Clinical Development, Legal and Regulatory)
· The Fellow’s primary responsibility is to support the needs of the Medical Team, while being offered the
unique opportunity to expand experience with projects in additional areas of interest

Goal
To become an effective member of a cross-functional Medical Affairs Team by developing the
transferrable skillset for future career success across various therapeutic areas.

Objectives
During this two-year US Medical Affairs Fellowship, the Fellow will:
· Gain a thorough understanding of Medical Affairs while collaborating cross-functionally (e.g., Andrew Koren, MD
Commercial, Field Medical, Regulatory, etc.) to apply learnings to US perspectives Head, US Medical
Cardiometabolic
· As a core team member, contribute to both US and Global projects that directly impact brand
development and life cycle management
· Lead in the execution, development, and planning of National and International Congresses,
Industry Expert Theaters, and Advisory Board meetings with top-tier Key Opinion Leaders
(KOLs)
· Facilitate discussion and identification of insights from the field and various matrix teams to
determine unmet medical needs and competitive intelligence insights and inform medical
strategy
· Engage thought leaders in scientific discussion during field-based activities with Medical Boseong Kang, PharmD
US Medical Strategy:
Science Liaisons (MSLs) Cardiovascular
· Work with the Publications and Scientific Communications groups to support brand strategy Fellow 2023-2025
· Work in collaboration with Health Economics Outcomes and Real World Evidence Groups to
generate impactful data aimed to improve the utilization of our therapies

Ideal Candidate
The ideal candidate for the Cardiovascular Medical Affairs Fellowship would have a desire to learn medical
strategy, tactics, and scientific communication, as well as to participate in data generation and publication
related activities that serve as the foundation of a medical affairs role within a global pharmaceutical
organization. Candidates with a passion for science, strong independent work ethic, comfort with
executing tasks with minimal oversight, ability to work proactively and collaboratively, problem-solving
mindset and objective thinking, excellent observational skills and attention to detail, and the ability to
manage multiple projects with competing deadlines are encouraged to apply.

26
2024-2025 FELLOWSHIP PROGRAM

Leadership Team
Co-Chiefs
• Lois Ko
• Cole Mackey
• Aman Kaur
• Boseong Kang
Speaker Liaison
• Marvin Nguyen
• Joseph Piotrowski
Brochure Leads
• Eugina Chiang
• Morgan Weber
• Jessica Blaze
• Matthew Grubic
FIND Leads
• Divya Rana
• Zachary Becouvarakis
Recruitment Co-Leads
• Jonathan Resch
• Nancy Nguyen
• Emily Wong
• Sima Bhagat
Sanofi Reception Co-Leads
• Tola Akinnuoye
• Prakrithi Ramesh
• Reyna Jash
Humor Captains
• Madison Blagrove
• Mariam Hanna
• Tiffany Lin

27
2024-2025 FELLOWSHIP PROGRAM

Fellowship
Alumni

Andrew Bogard, PharmD Dhanushya Raja, PharmD, MBA Loura Said, PharmD, MBA Joseph Eckart, PharmD
US Scientific Director, Cardiovascular Director, Director, Value & Access, Associate Director,
Type 1 Diabetes Thought Leader Liaison Oncology Global Medical Writing
US Managed Markets Strategic Marketing Pharmacovigilance & Clinical Documentation
Fellow 2008-2010 Fellow 2015-2017 Epidemiology Fellow 2016-2018
Fellow 2015-2017

Sagar Shah, PharmD Hamza Sarwar, PharmD Patrick LaFontaine, PharmD, MS Sally Habusta, PharmD, MHSA
Medical Science Liaison, Senior Manager, Global Health Economics & Value Associate Director,
Vaccines MMRC Operations Assessment Business Partner, Medical Writing
Global Medical Information Global Medical Information Oncology US/Global Health Regulatory Medical Writing
Fellow 2017-2018 Fellow 2018-2019 Economics & Value Assessment Fellow 2018-2020
Fellow 2018-2020

Romy Shah, PharmD Amanda Meisel, PharmD Ying Huang, PharmD Cori Gray, PharmD
Global Medical Information US Regulatory Affairs Lead Clinical Data Scientist Health Economics & Value
Content Manager, Global Regulatory Affairs Clinical Science and Operations Assessment Business Partner, MS I&I
Specialty Care Fellow 2019-2021 Fellow 2019-2021 US/Global Health Economics
Global Medical Information & Value Assessment
Fellow 2019-2020 Fellow 2019-2021

Heather Winter, PharmD Dharmi Shah, PharmD Sarah Soliman, PharmD Aniket Patel, PharmD
Regulatory Labeling Manager Associate Director, Global Medical Information Associate Director, Value &
US Consumer Healthcare R&D Global Labeling Strategy Content Manager, Vaccines Access, Cardiovascular
Fellow 2019-2021 Global Regulatory Global Medical Information Strategic Marketing
Affairs Labeling Fellow 2020-2021 Fellow 2020-2022
Fellow 2019-2021

28
 2024-2025 FELLOWSHIP PROGRAM

Fellowship
Alumni

Michael Saoud, PharmD, MBA Roshani Patel, PharmD Katherine Adams, PharmD, Polly Luo, PharmD
Clinical Scientist Manager, US Advertising and RPh, MBA, MSPH Medical Writer
Clinical Science and Promotion, Global Regulatory Medical Science Liaison, Regulatory Medical Writing
Operations Affairs Global Regulatory Affairs Vaccines - NC, SC US Medical Fellow 2020-2022
Fellow 2020-2022 Fellow 2020-2022 Strategy/MSL: Vaccines
Fellow 2020-2022

Henna Shah, PharmD Sarette Tilton, PharmD Andrew Vilcinskas, PharmD Pankti Kothari, PharmD
Associate Director, Contract HEVA Dupixent Business Partner, Lead, US Public Affairs & Patient Manager, North America
Development and Analytics Respiratory Diseases US/Global Advocacy General Medicines Regulatory Strategy
US Trade/Market Access Health Economics & Value US Public Affairs & Patient Global Regulatory Strategy
Fellow 2020-2022 Assessment Advocacy, General Medicine Fellow 2021-2023
Fellow 2020-2022 Fellow 2020-2022

Jodie Zheng, PharmD Carolina Guerreiro, PharmD, RPh Peter Tonsits, PharmD, RPh Tiffanie Tran, PharmD
US Transplant Scientific Director Medical Science Liaison, Medical Science Liaison, HEVA N&I Project Manager III
US/Global Medical Affairs/ Immunology - Mid-Atlantic Region Vaccines - CO, ID, MT, UT, WY US/Global Health Economics
Medical Strategy: Diabetes Global R&D and Medical Strategy Medical Affairs (MSL, Office-base) & Value Assessment
Fellow 2020-2022 Fellow 2021-2023 Fellow 2021-2023 Fellow 2021-2023

David Shelton, PharmD Jingzhi Yang, PharmD

Medical Science Liaison, Medical Science Liaison,
US Immunology Dermatology - PA, NJ, NY
US Medical Affairs US Consumer Healthcare
Fellow 2021-2023 Research & Development:
Personal Care
Fellow 2021-2023

29
 Rutgers Pharmaceutical Industry Fellowship Program
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey

Joseph A. Barone, Carolyn Seyss, Michael Toscani,

Pharm.D., F.C.C.P. Pharm.D., RUCIF Pharm.D.
Dean and Professor II Fellowship Director Research Professor,
Ernest Mario School of Institute for Pharmaceutical Industry Fellowship Director Emeritus
Pharmacy Fellowships Institute for Pharmaceutical
Rutgers University Ernest Mario School of Pharmacy Industry Fellowships
Ernest Mario School of
Program History Pharmacy
In 1984, at Rutgers, The State University of New Jersey, the Ernest Mario School of Pharmacy and two
pharmaceutical companies began a first-of-its-kind collaborative pilot program to evaluate the potential
contributions of clinically-trained pharmacists within a pharmaceutical industry practice setting. Following the
successful pilot, the Rutgers Pharmaceutical Industry Fellowship (RPIF) Program grew significantly and
expanded to include 27 companies within the pharmaceutical and biopharmaceutical industry and approximately
350 Fellows.

In 2002, Dr. Ernest Mario generously provided an endowment to establish the Institute for Pharmaceutical
Industry Fellowships to enhance and promote the role of pharmacists in industry through the RPIF Program.
The Institute staff members:
● provide leadership and administrative support
● promote quality, communication, scholarly activity, and professional development
● arrange specialized Fellowship training opportunities within the pharmaceutical and biopharmaceutical
industry.

In 2018, our Program expanded to offer interdisciplinary Fellows’ training by adding select physician Fellowship
opportunities to our well-established program.

The RPIF Program has thrived under the leadership of the founder, Dr. Joseph A. Barone, Dean and Professor II
of the Ernest Mario School of Pharmacy, Dr. Carolyn Seyss, the Director for the Institute for Pharmaceutical
Industry Fellowships, and Dr. Michael Toscani as the Director Emeritus.

The RPIF Program Certificate is now associated with special credentials so our alumni can now proudly identify
themselves as RUCIF (Rutgers University Certified Industry Fellow). Well over 1,500 Post-Doctoral Fellows
have completed the RPIF Program, most of whom are experiencing influential and rewarding careers in the
pharmaceutical and biopharmaceutical industry throughout the US and abroad. The RPIF Program has
Preceptors and Mentors from industry who share their knowledge and experiences with the Fellows through an
intense but closely-guided training program. Assignments and projects are challenging, meaningful, and
designed to enhance understanding of the pharmaceutical and biopharmaceutical industry and the Fellow’s
functional area(s). Our goal is to provide the environment for Fellows to build the foundations to fuel their careers
as future leaders in the industry.

Connect with us on social

media: @RutgersFellow
Professional Rutgers
Development Pharmaceutical
Series Industry Fellowship Program
All Fellows gather once monthly as a group to participate in the Professional Development Day (PDD) series,
Ernest
an important component of their training thatMario Schooltheofhands-on
complements Pharmacy experience provided at the partner
Rutgers,
companies. The PDDs are steered by aThe StateofUniversity
committee Fellows andof areNew Jersey
designed to enhance the Fellows’
leadership skills such as emotional intelligence, communication, critical decision making, and presentation
skills. Fellows develop skill sets under the guidance of external trainers and accomplished RPIF alumni. PDDs
also provide general knowledge about various aspects of drug development/commercialization and issues
facing the pharmaceutical and biopharmaceutical industry, and promote connectivity and a sense of community
among Fellows and alumni from different companies and disciplines.
The Fellows
JosephcanA. learn from each other
Barone, through
Carolyn individual and groupMichael
Seyss, presentationsToscani, on topics and issues related
to the pharmaceutical
Pharm.D., F.C.C.P. and biopharmaceutical
Pharm.D., RUCIF industry. The dynamic forum
Pharm.D. of PDD provides an opportunity for
open discussion and debate
Dean and Professor II amongFellowship
Fellows,Director
Rutgers faculty, and company Preceptors.
Research Professor, In addition, outside
Ernest Mario School of Institute for Pharmaceutical Industry Fellowship Director Emeritus
experts provide
Pharmacy
training and professional development in a variety of areas (e.g., tools for corporate success,
Fellowships Institute for Pharmaceutical
professional writing,
Rutgers presentations, meeting
University Ernest Mariofacilitation, negotiating, Industry
School of Pharmacy influencing, networking, conflict resolution,
Fellowships
giving and receiving feedback, and business etiquette). Other PDD guest speakers ofinclude senior industry
Ernest Mario School
Program History
executives, including our successful RPIF Program alumni, who share Pharmacy
their career paths, insights, and
In 1984, at Rutgers, The State University of New Jersey, the
experiences. Importantly, PDDs provide an excellent opportunity for Fellows Ernest Mario School of Pharmacy
to interact andother
with each two and
pharmaceutical companies began a first-of-its-kind collaborative pilot program to evaluate
develop lasting personal friendships and a strong professional network of Fellows, faculty, alumni, and other the potential
contributions of clinically-trained pharmacists within a pharmaceutical industry practice setting. Following the
industry executives.
successful pilot, the Rutgers Pharmaceutical Industry Fellowship (RPIF) Program grew significantly and
Key Program
expanded Features
to include 27 companies within the pharmaceutical and biopharmaceutical industry and approximately
The Rutgers
350 Fellows. Pharmaceutical Industry Fellowship Program FOSTERs the growth and development of future
pharmaceutical and biopharmaceutical industry professionals and leaders through key program features:
In 2002, Dr. Ernest
FamilyMarioof generously provided an
Leading Companies – endowment
Partners include to establish
severalthe Institute
of the for Pharmaceutical
top global
F
Industry Fellowships to enhance and promote the role of pharmacists in
pharmaceutical and biopharmaceutical companies and offer large to small company
The Institute staff members:
environments.
industry through the RPIF Program.

● provide Outstanding
leadership andAlumniadministrative support– Well over 1,500 alumni hold prominent positions
O
● promoteatquality, communication,
Track Record
scholarly
many leading companies, including activity, and C-suite
VP and professional
levels. development
● arrange specialized Fellowship training opportunities within the pharmaceutical and biopharmaceutical
S Strong Network — Fellows develop valuable, lasting connections with each other,
industry.alumni, Preceptors, and Rutgers EMSOP faculty.
Trusted and Proven Since 1984 — the Rutgers Fellowship Program is nationally
T recognized,
In 2018, our Program
opportunities tofuture
expanded to offer
trusted,
our well-established
leaders.
and interdisciplinary
proven as the key
program.
Fellows’
pathwaytraining by adding
to industry select physician
for pharmacists as Fellowship

Enhanced Career Development – Breadth of experiences informs career path

E
The RPIF Program
of the Ernest Mario
has thrived
choices,
School of
underchallenging
increasingly
Pharmacy,
the leadership
Dr. Carolyn
of the founder,
assignments
Seyss,
build Dr.
the
Joseph
depth
Director for the
creates opportunities - enhancing the potential for accelerated career paths.
A. Barone,and
of experience,
Institute
Dean
for
and Professor II
visibility
Pharmaceutical
Industry Fellowships, and Dr. Michael Toscani as the Director Emeritus.
R Rigorous Academic Component – Rutgers affiliation provides academic and
professional development opportunities.
The RPIF Program Certificate is now associated with special credentials so our alumni can now proudly identify
Rutgers, The
themselves asState
RUCIF University
(RutgersofUniversity
New Jersey, with over
Certified 67,000 Fellow).
Industry students in its three
Well campuses,
over 1,500 is one ofFellows
Post-Doctoral the
majorcompleted
have state university systems
the RPIF in themost
Program, United States.
of whom The
are New Jerseyinfluential
experiencing College of andPharmacy
rewarding was founded
careers in
in the
pharmaceutical and biopharmaceutical industry throughout the US and abroad. The RPIF Program has is part
1892 and was incorporated into the University in 1927. The Ernest Mario School of Pharmacy (EMSOP)
of Rutgers and
Preceptors Biomedical
MentorsandfromHealth
industrySciences (RBHS),
who share theirthe only state
knowledge school
and of pharmacy
experiences in New
with the Jersey,
Fellows with an
through
intense but closely-guided training program. Assignments and projects are challenging, meaningful, and on
approximately 1,350 students in its Doctor of Pharmacy degree program. The Rutgers EMSOP is located
the University’s
designed main understanding
to enhance science and technology campus in Piscataway,
of the pharmaceutical New Jersey.industry
and biopharmaceutical Becauseand of its
therelationship
Fellow’s
with and close proximity to most of the nation's leading pharmaceutical and biopharmaceutical companies,
functional area(s). Our goal is to provide the environment for Fellows to build the foundations to fuel their careers the
EMSOP
as future and the in
leaders RPIF
the Program
industry. are uniquely capable of providing Fellows with advanced training in the
pharmaceutical and biopharmaceutical industry.

Connect with us on social

media: @RutgersFellow
 Rutgers Pharmaceutical Industry Fellowship Program
Application Process and Eligibility Requirements:
Ernest Mario School of Pharmacy
Pharmacy Fellows for the Rutgers Pharmaceutical Industry Fellowship Program are selected on a nationally
competitive basis. Candidates Rutgers, The
must have State University
completed of New degree
a Doctor of Pharmacy Jerseyfrom an ACPE-accredited
institution before July 1 of the fellowship term.

How to Apply:
The RPIF Program is highly competitive. Candidates Required Items Submit by
will be selected for interviews on a rolling basis, so
we strongly encourage you to submit your Application with short- October 13th
Joseph A. Barone, Carolyn Seyss, answerMichael
questionsToscani,
application as soon as possible.
Pharm.D., F.C.C.P. Pharm.D., RUCIF Pharm.D.
Dean and Professor II Fellowship Director Letter of Intent
Research (LOI)
Professor, October 13th
Interested candidates
Ernest Mario School may
of submitInstitute
theirfor application
Pharmaceutical Industry Fellowship Director Emeritus
Pharmacy
with short-answer questions and Fellowships
supporting Institute for Pharmaceutical
Rutgers University Ernest Mario School of Pharmacy Curriculum Vitae (CV)
Industry Fellowships
October 13th
materials (letter of intent, curriculum vitae, and 3 Ernest Mario School of
letters ofHistory
Program recommendation) as soon as October 6, LettersPharmacy
of December 1st
2023 by visiting our website at: Recommendation
In 1984, at Rutgers, The State University of New Jersey, the Ernest Mario School of Pharmacy and two
https://pharmafellows.rutgers.edu/how-to-apply/
pharmaceutical companies began a first-of-its-kind collaborative (LORs)
pilot program to evaluate the potential
contributions of clinically-trained pharmacists within a pharmaceutical industry practice setting. Following the
All application
successful pilot,materials must
the Rutgers be submitted Industry Fellowship (RPIF) Program grew significantly and
Pharmaceutical
electronically
expanded to the27RPIF
to include Website
companies per instructions
within on
the pharmaceutical and biopharmaceutical industry and approximately
the site.
350 Fellows.

Your
In Letter
2002, of Intent
Dr. Ernest & Letters
Mario of Recommendation
generously provided an endowment to establish the Institute for Pharmaceutical
should be
Industry addressedto
Fellowships to:enhance and promote the role of pharmacists in industry through the RPIF Program.
The Institute staff members:
Joseph A. Barone,
● provide Pharm.D.,
leadership and F.C.C.P.
administrative support
Dean
● and Professor
promote II communication, scholarly activity, and professional development
quality,
Ernest Mario School
● arrange of Pharmacy
specialized Fellowship training opportunities within the pharmaceutical and biopharmaceutical
Rutgers, The State
industry. University of New Jersey
160 Frelinghuysen Road
Piscataway,
In NJ 08854-8020
2018, our Program expanded to offer interdisciplinary Fellows’ training by adding select physician Fellowship
opportunities to our well-established program.

The RPIF Program has thrived under the leadership of the founder, Dr. Joseph A. Barone, Dean and Professor II
of the Ernest Mario School of Pharmacy, Dr. Carolyn Seyss, the Director for the Institute for Pharmaceutical
Industry Fellowships, and Dr. Michael Toscani as the Director Emeritus.
Alliance of Industry Fellowship Associates Fellowship Offers
Recognizing that the
The RPIF Program choice ofisanow
Certificate Post-Doctoral
associatedIndustry Fellowship
with special is an so our alumni can now proudly identify
credentials
important decision,
themselves as RUCIF AIFA exists toUniversity
(Rutgers promote aCertified
common Industry
aspect ofFellow).
each of our
Well over 1,500 Post-Doctoral Fellows
program’s cultures by supporting a consensus first offer date of December
have completed the RPIF Program, most of whom are experiencing influential and rewarding careers in the
13, 2023 for all and
pharmaceutical fellowship candidates. industry throughout the US and abroad. The RPIF Program has
biopharmaceutical
Preceptors
We hope thatandother
Mentors from industry
academic who share their
and non-academic knowledge
Fellowship and experiences
Programs will with the Fellows through an
intense
respectbut
thisclosely-guided training
timeline to allow program.
for best Assignments
program and projects are challenging, meaningful, and
fit for candidates.
designed to enhance understanding of the pharmaceutical and biopharmaceutical industry and the Fellow’s
functional area(s). Our goal is to provide the environment for Fellows to build the foundations to fuel their careers
as future leaders in the industry.

Connectwith
Connect withus
uson
onsocial
social
media:@RutgersFellow
media: @RutgersFellow
 www.sanofi-us.com
www.sanofi-us.com
MAT-US-2305506-v1.0-08/2023
MAT-US-2205423-v3.0-09/2022

33